Lionco Pharmaceutical Group News

Announcement on the subsidiary\'s injectable cefuroxime passing the generic drug consistency evaluation

Nov 6 00:00

Convertible debt-to-equity conversion results and share change announcement

Oct 10 00:00

Announcement on the subsidiary levocarnitine injection passing the generic drug consistency evaluation

Sep 19 00:00

Announcement on the subsidiary\'s injectable cefazoxime sodium passing the generic drug consistency evaluation

Sep 5 00:00

Notice on the change of sponsor representative to continue to supervise

Aug 31 00:00

Announcement regarding the subsidiary's cephalosporin injection sodium sulbactam passing the generic consistency evaluation.

Aug 15 00:00

Announcement on Not Lowering the Conversion Price of Lingkang Convertible Bonds

Aug 7 00:00

Announcement regarding the expectation of meeting the share conversion price adjustment conditions for "Lingkang Convertible Bonds".

Jul 31 00:00

Announcement Regarding Full Subsidiary Obtaining Approval Notice for Clinical Trials of Drugs.

Jul 18 00:00

Announcement about the signing of a strategic cooperation framework agreement between the company and Laboratoire Bailly-Creat.

Jul 16 00:00

Legal opinion of Zhong Lun (Shenzhen) Law Firm on Lionco Pharmaceutical Group's second extraordinary general meeting of shareholders in 2024 in Peking.

Jul 15 00:00

Announcement on downward revision of the conversion price of Lingkang Convertible Bonds and suspension/resumption of conversion.

Jul 15 00:00

Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.

Jul 15 00:00

2024 Second Interim Shareholder Meeting Documentation

Jul 5 00:00

Announcement on the approval of the new specification of the subsidiary Acetylcysteine Injection.

Jul 4 00:00

Announcement of convertible bonds conversion results and share changes.

Jul 3 00:00

Announcement regarding the optional puttable results for 'Lingkang Convertible Bond'.

Jul 3 00:00

The Third Reminder on the Optional Redemption of Lingkang Convertible Bonds.

Jun 28 00:00

The Second Notice for the Optional Redemption of Lingkang Convertible Bonds.

Jun 26 00:00

Announcement regarding the board of directors' proposal to downwardly revise the conversion price of Lingkang Convertible Bonds.

Jun 25 00:00